PWA
SGMO

Physician Wealth Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Physician Wealth Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,271
Closed -$688 – 2038
2025
Q2 		$688 Buy
+1,271
New +$755 ﹤0.01% 1612

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Physician Wealth Advisors's SGMO Position: Q3 2025 in Review

Physician Wealth Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2025, closing a stake of 1,271 shares — an estimated $688 sold.

Physician Wealth Advisors first reported a position in SGMO in Q2 2025 and held it in 1 quarter. The position peaked at $688 in Q2 2025. 112 funds tracked by Wall St. Rank hold SGMO as of Q3 2025.

  • Physician Wealth Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2025 after selling out during the quarter.
  • Physician Wealth Advisors sold 1,271 SANGAMO THERAPEUTICS INC shares in Q3 2025, an estimated $688.
  • Physician Wealth Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2025 and held it in 1 quarter.
  • Physician Wealth Advisors's SANGAMO THERAPEUTICS INC position peaked at $688 in Q2 2025.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2025.

Based on Physician Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.